Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

professional disposables international inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antimicrobial hand sanitizer to decrease bacteria on the skin. dries in seconds.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

lil' drug store products, inc. - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - upset stomach reliever and anti-diarrheal relieves: - indigestion - nausea - heartburn - diarrhea - upset stomach associated with these symptoms

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

professional disposables international, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to decrease bacteria on the skin

Australia - engleză - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cefaclor monohydrate, quantity: 26.22 mg/ml (equivalent: cefaclor, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - ceclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. ceclor appears to be as effective as phenoxymethyl penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of ceclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cefaclor monohydrate, quantity: 52.45 mg/ml (equivalent: cefaclor, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - ceclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. ceclor appears to be as effective as phenoxymethyl penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of ceclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - lifitegrast, quantity: 50 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; sodium hydroxide; sodium thiosulfate pentahydrate; water for injections; dibasic sodium phosphate - xiidra is indicated for the treatment of moderate to severe dry eye disease in adults for whom prior use of artificial tears has not been sufficient.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - ciltacabtagene autoleucel, quantity: 500000 cells/kg - injection, intravenous infusion - excipient ingredients: dimethyl sulfoxide - cellular therapies - carvykti is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least three prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-cd38 antibody.

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

boehringer ingelheim limited - dipyridamole, acetylsalicylic acid - capsules modified release - 200/25 mg/mg - platelet aggregation inhibitors excl. heparin

Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - dipyridamole; aspirin - modified-release capsule - 200mg ; 25mg

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - cetirizine dihydrochloride - film-coated tablet - 10 milligram(s) - piperazine derivatives; cetirizine